Sanger sequencing

Sanger sequencing
Name	Frederick Sanger
Birth date	13 August 1918
Death date	19 November 2013
Known for	Dideoxy sequencing method
Awards	Nobel Prize in Chemistry (1958, 1980)

Sanger sequencing is a DNA sequencing technique developed in the 1970s that enabled determination of nucleotide order in DNA fragments. It transformed molecular biology, accelerating projects such as the Human Genome Project, and influenced technologies at institutions like the Wellcome Trust, Cold Spring Harbor Laboratory, and Broad Institute. Invented by Frederick Sanger, the method underpinned advances in labs from University of Cambridge to industrial sites like Applied Biosystems and shaped fields connected to National Institutes of Health funding.

History

The origins trace to work by Frederick Sanger at the MRC Laboratory of Molecular Biology in Cambridge, where early protein sequencing achievements led to nucleic acid strategies that contrasted with methods from groups at Max Planck Society and University of California, Berkeley. Publication in 1977 came amid parallel efforts at Walter Gilbert's lab, and subsequent uptake was propelled by company innovations from PerkinElmer and Thermo Fisher Scientific. High-impact projects including the Human Genome Project and collaborations among Wellcome Trust Sanger Institute and UCSC Genome Browser popularized the method, while awards such as the Nobel Prize in Chemistry recognized its creators.

Methodology

The technique uses selective incorporation of chain-terminating dideoxynucleotides (ddNTPs) during DNA synthesis, with enzymes like T7 RNA polymerase or DNA polymerase I variants in reactions originally optimized in labs at Cold Spring Harbor Laboratory and European Molecular Biology Laboratory. Template preparation often relies on vector systems developed at places like Stanford University and Massachusetts Institute of Technology; primers are synthesized chemically following protocols from groups at DuPont and Genentech. Four parallel reactions or fluorescently labeled ddNTPs allow separation by size using electrophoresis devices from manufacturers such as Applied Biosystems and Beckman Coulter, with detection strategies influenced by work at Max Planck Institute for Biophysical Chemistry. Sequence reads are produced and assembled using software concepts pioneered at University of Washington and European Bioinformatics Institute.

Applications

The method enabled gene discovery projects at institutions like Harvard University, Yale University, and Columbia University; characterization of pathogens at Centers for Disease Control and Prevention and Walter Reed Army Institute of Research; and forensic assays used by agencies influenced by standards from FBI. Clinical diagnostics at hospitals such as Mayo Clinic and Johns Hopkins Hospital used the technique for mutation detection in genes studied by groups at National Human Genome Research Institute and Dana-Farber Cancer Institute. Conservation genetics initiatives from Smithsonian Institution and population studies at Stanford University also deployed the approach, as did industrial projects at Merck and Pfizer for small-region validation.

Advantages and Limitations

Advantages include high accuracy demonstrated in comparative assessments by teams at European Molecular Biology Laboratory and long-established reliability in reference labs like NIH Clinical Center. The method provides long read lengths favorable for assembly tasks, a feature exploited in projects at Wellcome Trust Sanger Institute. Limitations emerged with throughput constraints addressed by sequencing centers such as Broad Institute; cost per base and scalability issues compared with platforms from Illumina and Pacific Biosciences led many large-scale endeavors like the 1000 Genomes Project to adopt next-generation approaches. Practical constraints also involve reagent supply chains influenced by corporations including Thermo Fisher Scientific and instrumentation maintenance at core facilities such as those at University of Oxford.

Variants and Automation

Modifications included fluorescent labeling and capillary electrophoresis advances introduced by firms like Applied Biosystems, enabling automation at high-throughput centers such as Wellcome Trust Sanger Institute and sequencing cores in universities like University of California, San Francisco. Nested PCR approaches used in clinical genetics traced protocols to laboratories at Mayo Clinic and Addenbrooke's Hospital. Integrated automations combined liquid handling robots from Tecan and informatics pipelines developed at European Bioinformatics Institute, while multiplexing schemes drew on methods from Cold Spring Harbor Laboratory and industrial genetics workflows at Genentech.

Data Analysis and Interpretation

Electropherograms produced require base-calling algorithms evolved from early software at University of Washington and error models characterized by investigators at European Molecular Biology Laboratory. Sequence assembly and alignment use algorithms influenced by work at Broad Institute and visualization tools from UCSC Genome Browser and Ensembl at European Bioinformatics Institute. Quality metrics and variant interpretation tie into databases curated by National Center for Biotechnology Information, ClinVar at NCBI, and clinical interpretation frameworks developed at American College of Medical Genetics and Genomics. Labs at Johns Hopkins Hospital and Mayo Clinic integrate Sanger confirmation into pipelines initiated by high-throughput studies from Human Genome Project collaborators.

Ethical, Legal, and Practical Considerations

Clinical use raises consent and reporting questions addressed by committees at World Health Organization and policies from Food and Drug Administration. Intellectual property and licensing issues intersected with firms like Applied Biosystems and research institutions including Wellcome Trust, influencing deployment in public health labs such as Centers for Disease Control and Prevention. Data sharing norms shaped by Human Genome Project and repositories like GenBank informed practice, while practical lab accreditation and quality assurance align with standards from College of American Pathologists and regulatory frameworks by Clinical Laboratory Improvement Amendments enforcement at Centers for Medicare & Medicaid Services.

Category:DNA sequencing